Momentum Biotechnologies

Momentum Biotechnologies is a specialized mass spectrometry service provider and a discovery partner for global biopharmaceutical clients. The company’s core team of scientists and engineers has been working together since the establishment of the RapidFire platform in 2000 (which was later sold to Agilent) and has been providing services to clients using RapidFire MS since 2004. Since 2015, the team has been operating under the name PureHoney Technologies to serve its clients. Current services include ligand binding, irreversible covalent binding, functional and biomarker assays based on affinity selection mass spectrometry, as well as bioanalytical and proteomics services.